(Q40457658)

20 September 2017

1 reference

title

Analogs of alkyllysophospholipids: Chemistry, effects on the molecular level and their consequences for normal and malignant cells (English)

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

23 June 2024

author name string

H. Brachwitz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630930

23 June 2024

C. Vollgraf

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630930

23 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7630930

23 June 2024

publication date

1 April 1995

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:016372589500001W?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

https://api.elsevier.com/content/article/PII:016372589500001W?httpAccept=text/plain

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Pharmacology & Therapeutics

23 June 2024

published in

1 reference

20 September 2017

volume

66

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

39-82

1 reference

Differential effects of ether lipids on the activity and secretion of interleukin-1 and interleukin-2

20 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Selective destruction of human leukemic cells by alkyl-lysophospholipids

23 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Alkyl-lysophospholipid induced suppression of human lymphocyte response to mitogens and selective killing of lymphoblasts

23 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Cytotoxic effector cell function at different stages of human monocyte-macrophage maturation

23 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Tumor cytotoxicity of human macrophages after incubation with synthetic analogues of 2-lysophosphatidylcholine

23 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Biochemical evidence for the role of alkyl-lysophospholipids on liver sialyltransferase

23 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Cytogenetic effects of an alkyl-lysophospholipid derivative in human peripheral lymphocytes exposed in vitro and in vivo

23 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells

23 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Antineoplastic activity of synthetic lysophospholipid analogs

23 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Membrane-interactive lipids as experimental anticancer drugs

23 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Metastatic growth of 3-Lewis lung carcinoma in mice treated with alkyl-lysophospholipids and lysophospholipid-induced peritoneal macrophages

23 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Alkyl-lysophospholipids inhibit the growth of hypernephroid carcinomas in vitro

23 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Alkyl-lysophospholipids lack influence on the occurrence of radiation-induced lymphomas and AKR-leukemia

23 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Cytotoxic effects of alkyl-lysophospholipids in human brain tumor cells.

23 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Ether lipid derivatives: antineoplastic activity in vitro and the structure-activity relationship.

23 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Protection by the alkyllysophospholipid, 1-octadecyl-2-methoxy-rac-glycero-3-phosphocholine, but not by the retinoid etretinate against leukemia development in DMBA-treated Long-Evans rats

23 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Modulation of chemical carcinogenesis in rats by alkyl lysophospholipids

23 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Antitumor activity of alkylphosphocholines and analogues in methylnitrosourea-induced rat mammary carcinomas

23 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Hexadecylphosphocholine differs from conventional cytostatic agents.

23 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Multiple effects of antitumor alkyl-lysophospholipid analogs on the cytosolic free Ca2+ concentration in a normal and a breast cancer cell line

23 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines

23 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Is metabolism an important arbiter of anticancer activity of ether lipids? Metabolism of SRI 62-834 and hexadecylphosphocholine by [31P]-NMR spectroscopy and comparison of their cytotoxicities with those of their metabolites

23 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Dietary supplementation with ether-linked lipids and tissue lipid composition

23 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Effects of a synthetic lysolecithin analog on the phase transition of mixtures of phosphatidylethanolamine and phosphatidylcholine

23 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Synthesis of thioether phosphocholine analogues

23 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Effect of octadecylmethylglycerophosphocholine and hexadecylmethylglycerol on arachidonic acylation or release in macrophages

23 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Halo lipids. V. Synthesis, nuclear magnetic resonance spectra and cytostatic properties of halo analogues of alkyllysophospholipids

23 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Cytostatic activity of synthetic O-alkylglycerolipids

23 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Halo lipids. 10. Synthesis and cytostatic activity of O-alkylglycerophospho-L-serine analogs

23 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Evidence for abrogation of oncogene-induced radioresistance of mammary cancer cells by hexadecylphosphocholine in vitro.

23 June 2024

60

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Structure-cytotoxicity studies on alkyl lysophospholipids and some analogs in leukemic blasts of human origin in vitro

23 June 2024

67

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Alkyl-linked diglycerides inhibit protein kinase C activation by diacylglycerols

23 June 2024

68

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Rapid synthesis of 2-desoxy-2-amino-3-phosphocholine-glycerinic-acid- alkylester, 1-alkyl-1-desoxy- and 1-O-alkyl-2-desoxy-2-amino-sn-glycero-3- phosphocholines, -3-phospho-N,N'-dimethylethanolamine and -3-phospho-Fmoc- serine-methylester

23 June 2024

69

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Platelet-activating factor and its methoxy-analogue ET-18-OCH3 stimulate immediate early gene expression in rat astroglial cultures

23 June 2024

70

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Differential cytotoxicity of an ether lipid on lymphoma and bone marrow cells and its role in purging malignant lymphoid cells from remission bone marrow contaminated with tumor cells

23 June 2024

73

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation

23 June 2024

74

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Role of cell cholesterol in modulating antineoplastic ether lipid uptake, membrane effects and cytotoxicity.

23 June 2024

75

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Increased ether lipid cytotoxicity by reducing membrane cholesterol content

23 June 2024

76

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. A possible basis for its selective action

23 June 2024

77

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

The effect of culture medium composition on ether lipid cytotoxic activity

23 June 2024

78

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

The induction of apoptosis is a common feature of the cytotoxic action of ether-linked glycerophospholipids in human leukemic cells.

23 June 2024

80

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Clonogenicity of normal and malignant hematopoietic progenitor cells after exposure to synthetic alkyl-lymphospholipids.

23 June 2024

82

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Phospholipid synthesis: Oxazaphospholanes and dioxaphospholanes as intermediates

23 June 2024

83

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Synthesis of glycerophospholipids

23 June 2024

84

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

phospholipid biosynthetic process

23 June 2024

85

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Synthesis of hexadecylphosphocholine (miltefosine)

23 June 2024

87

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Effect of alkyl-lysophospholipid on glioblastoma cell invasion into fetal rat brain tissue in vitro

23 June 2024

92

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Synthesis of enantiomerically pure lysophosphatidylinositols and alkylphosphoinositols

23 June 2024

94

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Metabolism of ether phospholipids and analogs in neoplastic cells

23 June 2024

96

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Cytotoxic activity of lysophosphatidylcholine analogues on human lymphoma Raji cells

23 June 2024

97

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Investigations on the cellular uptake of hexadecylphosphocholine

23 June 2024

98

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Surface membrane O-alkyl lipid concentration and metastasizing behavior in transplantable rat mammary carcinomas

23 June 2024

99

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Antineoplastic activity of the thioether lysophospholipid derivative BM 41.440 in vitro.

23 June 2024

100

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

An efficient and stereoselective synthesis of platelet-activating factors and the enantiomers from D- and L- tartaric acids

23 June 2024

101

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Catalytic asymmetric epoxidation and kinetic resolution: modified procedures including in situ derivatization

23 June 2024

103

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

The phospholipid analogue, hexadecylphosphocholine, inhibits protein kinase C in vitro and antagonises phorbol ester-stimulated cell proliferation

23 June 2024

104

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Uptake, subcellular distribution and metabolism of the phospholipid analogue hexadecylphosphocholine in MDCK cells

23 June 2024

107

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Effects of the ether phospholipid AMG-PC on mast cells are similar to that of the ether lipid AMG but different from that of the analogue hexadecylphosphocholine

23 June 2024

109

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Cytotoxic and cytostatic effects of antitumor agents induced at the plasma membrane level

23 June 2024

110

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

The phospholipid- and calcium-dependent protein kinase as a target in tumor chemotherapy

23 June 2024

111

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Synthesis and antineoplastic properties of ether-linked thioglycolipids

23 June 2024

113

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

The phospholipid analogue hexadecylphosphocholine inhibits phosphatidylcholine biosynthesis in Madin-Darby canine kidney cells

23 June 2024

116

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Preclinical activity of ilmofosine against human tumor colony forming units in vitro

23 June 2024

117

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists.

23 June 2024

118

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Alkyllysophospholipid ET-18-OCH3 acts as an activator of protein kinase C in HL-60 cells

23 June 2024

119

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Adsorption and uptake of the alkyllysophospholipid ET-18-OCH3 by HL-60 cells during induction of differentiation by dimethylsulfoxide

23 June 2024

120

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Protein kinase C is not involved in the cytotoxic action of 1-octadecyl-2-O-methyl-sn-glycerol-3-phosphocholine in HL-60 and K562 cells

23 June 2024

121

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

A facile asymmetric synthesis of glycerol phospholipids via tritylglycidol prepared by the asymmetric epoxidation of allyl alcohol. Thiolester and thioether analogs of phosphatidylcholine.

23 June 2024

123

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages

23 June 2024

127

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Phase I trial of the thioether phospholipid analogue BM 41.440 in cancer patients

23 June 2024

128

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

In vivo antitumor activity of ilmofosine

23 June 2024

129

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Antitumor activity of ilmofosine (BM 41.440) in the3Lewis-lung carcinoma model

23 June 2024

130

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Therapeutic activity of a thioether-lipid conjugate of 1-beta-D-arabinofuranosylcytosine in human colorectal cancer xenografts

23 June 2024

131

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)

23 June 2024

132

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Investigation into the immunological effects of miltefosine, a new anticancer agent under development

23 June 2024

133

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Experimental therapeutic studies with miltefosine in rats and mice

23 June 2024

134

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Alkylphosphocholines: a new class of membrane-active anticancer agents

23 June 2024

135

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Cross-resistance pattern of cell lines selected for resistance towards different cytotoxic drugs to membrane-toxic phospholipids in vitro.

23 June 2024

136

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Effects of antineoplastic phospholipids on parameters of cell differentiation in U937 cells

23 June 2024

139

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Early effects of hexadecylphosphocholine on gene expression in leukemia cell lines

23 June 2024

140

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Hexadecylphosphocholine induces interferon-gamma secretion and expression of GM-CSF mRNA in human mononuclear cells

23 June 2024

141

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Inhibition of cellular transport systems by alkyl phospholipid analogs in HL-60 human leukemia cells

23 June 2024

145

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Synergistic enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by the ether lipid analogue BM41440, an inhibitor of protein kinase C

23 June 2024

146

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Nucleoside conjugates. 11. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine and cytidine conjugates of thioether lipids

23 June 2024

147

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

1-β-D-arabinofuranosylcytosine conjugates of ether and thioether phospholipids. A new class of ara-C prodrug with improved antitumor activity

23 June 2024

148

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of optical isomers of ether and thioether lipids

23 June 2024

149

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Modification of membrane phospholipid composition by choline analogues induces differentiation of cultured mouse myeloid leukemia cells

23 June 2024

151

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Antileukemic effect of alkyl phospholipids. I. Inhibition of proliferation and induction of differentiation of cultured myeloid leukemia cells by alkyl ethyleneglycophospholipids

23 June 2024

152

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Antileukemic effect of alkyl phospholipids. II. Prolongation of survival times of leukemic mice by alkyl ethyleneglycophospholipids

23 June 2024

153

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Induction of differentiation of human myeloid leukemia HL-60 cells by novel nonphosphorus alkyl ether lipids

23 June 2024

155

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Antitumor activity of SRI 62-834, a cyclic ether analog of ET-18-OCH3.

23 June 2024

156

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Cyclic oxygen analogues of alkyl-lysophospholipids. Synthesis and neoplastic cell growth inhibitory properties

23 June 2024

157

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Synthesis and biological evaluation of ether-linked derivatives of phosphatidylinositol

23 June 2024

158

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Synthesis of the spin-labeled derivative of an ether-linked phospholipid possessing high antineoplastic activity

23 June 2024

159

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Inhibition of proliferation and induction of differentiation of human and mouse myeloid leukemia cells by new ethyleneglycol-type nonphosphorus alkyl ether lipids.

23 June 2024

165

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Chemical synthesis and physiological activity of sulfonium analogues of platelet activating factor

23 June 2024

166

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Morphological changes of adherent and nonadherent cells by treatment with hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine observed by scanning electron microscopy

23 June 2024

167

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Unidirectional membrane uptake of the ether lipid antineoplastic agent edelfosine by L1210 cells

23 June 2024

170

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Failure to detect mutagenic effects of anti-tumor alkyl-lysophospholipids.

23 June 2024

172

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Antileukemic agent alkyllysophospholipid regulates phosphorylation of distinct proteins in HL60 and K562 cells and differentiation of HL60 cells promoted by phorbol ester

23 June 2024

173

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid

23 June 2024

175

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Inhibition by an alkyl-lysophospholipid of the uptake of epidermal growth factor in human breast cancer cell lines in relation to epidermal growth factor internalization

23 June 2024

176

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Increase of transferrin binding induced by an alkyl-lysophospholipid in breast cancer cells

23 June 2024

177

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations

23 June 2024

179

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Antitumor activity of synthetic alkylphospholipids with or without PAF activity

23 June 2024

182

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Molecular dynamics of antitumor ether-linked phospholipids in model membranes: a spin-label study

23 June 2024

183

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Inhibition of proliferation of Ehrlich ascites carcinoma cells in vitro and in vivo by halogeno analogues of long chain acyl- and alkylglycerols

23 June 2024

185

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Cytostatic effects of various alkyl phospholipid analogues on different cells in vitro

23 June 2024

186

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

The interaction of liposomes with cells: The relation of cell specific toxicity to lipid composition

23 June 2024

187

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Elevation of leukemic cell intracellular calcium by the ether lipid SRI 62-834

23 June 2024

188

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

ON THE STRUCTURE OF CARDIOLIPIN

23 June 2024

189

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

In vitro and in vivo cytotoxicity of alkyl lysophospholipid ET-18-OCH3 and thioether lipid BM 41.440

23 June 2024

190

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Lack of enantio-selectivity in the in vitro antitumour cytotoxicity and membrane-damaging activity of ether lipid SRI 62-834: further evidence for a non-receptor-mediated mechanism of action

23 June 2024

192

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

The role of intracellular free calcium mobilization in the mechanism of action of antitumour ether lipids SRI 62-834 and ET18-OMe.

23 June 2024

193

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Perturbations of cellular acylation processes by the synthetic alkyl-lysophospholipid 1-O-octadecyl-2-O-methylglycero-3-phosphocholine do not correlate with inhibition of proliferation of MCF7 and T84 cell lines

23 June 2024

195

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

The differential susceptibility of A427 and A549 cell lines to the growth-inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids

23 June 2024

196

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Metabolism of alkyl lysophospholipid in epithelial cancer cell lines and inhibition of cell growth

23 June 2024

197

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Morphological effects of an antitumor agent on human esophageal carcinoma cells in vitro

23 June 2024

198

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Synthesis and Biosynthesis of Alkoxylipids

23 June 2024

200

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Synthesis of biologically active ether lipids

23 June 2024

201

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Biosynthesis and biotransformation of ether lipids

23 June 2024

203

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Synthesis and biological activity of novel quaternary ammonium derivatives of alkylglycerols as potent inhibitors of protein kinase C.

23 June 2024

205

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Invasion and metastasis control: implications for increased therapeutic index of antitumor drugs

23 June 2024

206

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Synthesis and evaluation of neoplastic cell growth inhibition of 1-N-alkylamide analogues of glycero-3-phosphocholine

23 June 2024

207

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Phospholipid derivatives of nucleoside analogs as prodrugs with enhanced catabolic stability

23 June 2024

208

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Alteration of DNA topoisomerase II activity during infection of H9 cells by human immunodeficiency virus type 1 in vitro: a target for potential therapeutic agents

23 June 2024

209

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Induction of tumor cell differentiation by alkylphosphocholines: a new approach for in vitro screening

23 June 2024

210

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Phase behavior of the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphochloline

23 June 2024

211

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Inhibition of protein kinase C by semisynthetic phospholipid plasmanyl-(N-acyl)-ethanolamine, a nontoxic antitumor preparation

23 June 2024

213

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Hexadecanoic and neuraminic acid incorporations in two rat colon carcinoma cell lipids: Selective influence of 1-O-octadecyl 2-O-methyl-3-phosphocholine on glycerolipid and ganglioside biosynthesis

23 June 2024

214

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids

23 June 2024

215

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Early and selective induction of apoptosis in human leukemic cells by the alkyl-lysophospholipid ET-18-OCH3.

23 June 2024

216

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Synthesis of sulfur analogues of alkyl lysophospholipid and neoplastic cell growth inhibitory properties

23 June 2024

217

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Synthesis of phosphocholine and quaternary amine ether lipids and evaluation of in vitro antineoplastic activity

23 June 2024

218

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Lysophosphatidylcholine (lysolecithin) and its synthetic analogues. Immunemodulating and other biologic effects

23 June 2024

223

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

The relationship between cytosolic Ca2+, sn-1,2-diacylglycerol and inositol 1,4,5-trisphosphate elevation in platelet-activating-factor-stimulated rabbit platelets. Influence of protein kinase C on production of signal molecules

23 June 2024

225

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Anti-neoplastic action of peritoneal macrophages following oral administration of ether analogues of lysophospholipids

23 June 2024

227

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Neoplastic cell inhibition with new ether lipid analogs.

23 June 2024

228

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

In vitro antiproliferative activity of combinations of ether lipid analogues and DNA-interactive agents against human tumor cells

23 June 2024

229

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Effects of antineoplastic ether lipids on model and biological membranes

23 June 2024

230

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Membrane damage in leukemic cells induced by ether and ester lipids: an electron microscopic study

23 June 2024

231

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Inhibition of Na,K-ATPase and sodium pump by anticancer ether lipids and protein kinase C inhibitors ET-18-OCH3 and BM 41.440.

23 June 2024

233

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Inhibition of phospholipase C delta by hexadecylphosphorylcholine and lysophospholipids with antitumor activity

23 June 2024

240

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Studies on nucleotide diphosphate diacylglycerol specificity of acidic phospholipid biosynthesis in rat liver subcellular fractions

23 June 2024

244

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Signalling pathways as targets for anticancer drug development

23 June 2024

245

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Inhibitors of phosphatidylinositol signalling as antiproliferative agents

23 June 2024

246

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Evaluation of combinations of antineoplastic ether phospholipids and chemotherapeutic drugs

23 June 2024

247

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Tumor cell kinetics following antineoplastic ether phospholipid treatment

23 June 2024

249

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Flow cytometric monitoring of anthracycline accumulation after anti-neoplastic ether phospholipid treatment

23 June 2024

252

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

A Phospholipid Derivative of Cytosine Arabinoside and Its Conversion to Phosphatidylinositol by Animal Tissue

23 June 2024

253

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

In vitro and in vivo antitumoral activity of alkylphosphonates

23 June 2024

254

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Synthesis of alkylphosphonates, a new class of antineoplastic agents

23 June 2024

255

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Sensitivity of human hematopoietic cell lines to an alkyl-lysophospholipid-derivative.

23 June 2024

256

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Destruction of human solid tumors by alkyl lysophospholipids

23 June 2024

257

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Inhibition of protein kinase C by ether-linked lipids is not correlated with their antineoplastic activity on WEHI-3B and R6X-B15 cells.

23 June 2024

258

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Two different sites of action for platelet activating factor and 1-O-alkyl-2-O-methyl-sn-glycero-3-phosphocholine on platelets and leukemic cells

23 June 2024

259

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

1-O-hexadecyl-2-O-methyl-sn-glycero-3-phosphocholine inhibits diacylglycerol kinase in WEHI-3B cells

23 June 2024

260

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Role of the host tissue in the anti-invasive activity of the alkyllysophospholipid, ET-18-OCH3, in vitro.

23 June 2024

262

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Therapeutic activity of ET-18-OCH3 and hexadecylphosphocholine against mammary tumors in BD-VI rats

23 June 2024

263

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro

23 June 2024

264

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Inhibition of the growth of human lung cancer cells by alkyl-lysophospholipid analogs

23 June 2024

265

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Tumor necrosis factor release by murine macrophages stimulated by the cytotoxic ether lipid 1-O-hexadecyl-2-O-methyl-SN-glycero-3-phosphorylcholine (ET-18-O-OCH3)

23 June 2024

267

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Effects of hexadecylphosphocholine on protein kinase C and TPA-induced differentiation of HL60 cells

23 June 2024

269

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines

23 June 2024

270

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Cytostatic activity of new synthetic anti-tumor aza-alkyllysophospholipids

23 June 2024

271

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Recent developments in the chemistry of phospholipids

23 June 2024

272

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Structure-activity relationships of four anti-cancer alkylphosphocholine derivatives in vitro and in vivo

23 June 2024

274

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Acetylcholine-like effects of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine ('platelet-activating factor') and its analogues in exocrine secretory glands

23 June 2024

275

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

EGF binding is quantitatively related to growth in node-positive breast cancer.

23 June 2024

277

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Antineoplastic activity and tolerability of a novel heterocyclic alkylphospholipid, D-20133

23 June 2024

279

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Increased membrane permeability for an antitumoral alkyl lysophospholipid in sensitive tumor cells

23 June 2024

280

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Effect of lipid derivatives on invasion in vitro and on surface glycoproteins of three rodent cell types

23 June 2024

282

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Effect of lysolecithin and analogs on mouse ascites tumors

23 June 2024

284

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Modulation of CTP:phosphocholine cytidylyltransferase translocation by oleic acid and the antitumoral alkylphospholipid in HL-60 cells

23 June 2024

286

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Syntheses and biological activities of N-alkyl- and N-alkenylcarbamoyl phospholipids

23 June 2024

289

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Cytotoxic liponucleotide analogs. II. Antitumor activity of CDP-diacylglycerol analogs containing the cytosine arabinoside moiety

23 June 2024

290

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity

23 June 2024

292

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Synthesis and antitumor activity of new alkylphospholipids containing modifications of the phosphocholine moiety

23 June 2024

293

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Hexadecylphosphocholine, a new ether lipid analogue. Studies on the antineoplastic activity in vitro and in vivo

23 June 2024

295

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Antitumoral activity of alkylphosphocholines and analogues in human leukemia cell lines

23 June 2024

296

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Effect of alkyl-lysophospholipid analogs on the morphology of a murine lymphoma cell line

23 June 2024

297

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

HL-60 cells become resistant towards antitumor ether-linked phospholipids following differentiation into a granulocytic form

23 June 2024

298

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Accumulation of an alkyl lysophospholipid in tumor cell membranes affects membrane fluidity and tumor cell invasion.

23 June 2024

300

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Effect of ether lipids on mouse granulocyte-macrophage progenitor cells

23 June 2024

302

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid

23 June 2024

305

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation

23 June 2024

306

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Bone marrow purging in acute leukemia with alkyl-lysophospholipids: a new family of anticancer drugs

23 June 2024

308

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

The effect of alkyl-lysophospholipids on tritiated thymidine incorporation and clonogenicity in vitro of normal and leukemic human cells

23 June 2024

309

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Experimental studies on the role of alkyl lysophospholipids in autologous bone marrow transplantation

23 June 2024

311

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Effect of cryopreservation on purging of leukemic marrow with alkyl-lysophospholipids

23 June 2024

312

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results

23 June 2024

313

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Comparison of selective cytotoxicity of alkyl lysophospholipids

23 June 2024

314

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents

23 June 2024

316

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Metabolism of ether glycolipids with potentially antineoplastic activity by Ehrlich ascites tumor cells

23 June 2024

317

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Formation of complex ether lipids from 1-O-alkylglycerols in cell suspension cultures of rape

23 June 2024

318

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Antagonism of phorbol-ester-stimulated phosphatidylcholine biosynthesis by the phospholipid analogue hexadecylphosphocholine

23 June 2024

320

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D.

23 June 2024

321

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Activation of mouse peritoneal macrophages by lysophospholipids and ether derivatives of neutral lipids and phospholipids

23 June 2024

323

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Activation of macrophages by ether analogues of lysophospholipids

23 June 2024

324

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

In vitro investigations on the antineoplastic effect of hexadecylphosphocholine

23 June 2024

325

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Augmentation and suppression of release of tumor necrosis factor from macrophages by negatively charged phospholipids.

23 June 2024

326

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Antitumor effects of alkylphosphocholines in different murine tumor models: use of liposomal preparations.

23 June 2024

328

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Interstitial chemotherapy of experimental gliomas.

23 June 2024

330

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues

23 June 2024

331

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

The relationship between cellular ether glycerophospholipid content and sensitivity of cancer cells to 1-O-octadecyl-2-O-methyl-glycerophosphocholine

23 June 2024

332

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00001-W

23 June 2024

Identifiers

1 reference

20 September 2017

1 reference